Tumor-Microenvironment-Induced Degradation of Ultrathin Gadolinium Oxide Nanoscrolls for Magnetic-Resonance-Imaging-Monitored, Activatable Cancer Chemotherapy

Angew Chem Int Ed Engl. 2019 May 20;58(21):6880-6885. doi: 10.1002/anie.201812972. Epub 2019 Feb 14.

Abstract

The development of biodegradable inorganic nanoparticles with a tumor microenvironment-activated therapeutic mode of action is urgently needed for precision cancer medicine. Herein, the synthesis of ultrathin lanthanide nanoscrolls (Gd2 O3 NSs) is reported, which biodegrade upon encountering the tumor microenvironment. The Gd2 O3 NSs showed highly controlled magnetic properties, which enabled their high-resolution magnetic resonance imaging (MRI). Importantly, Gd2 O3 NSs degrade in a pH-responsive manner and selectively penetrate tumor tissue, enabling the targeted release of anti-cancer drugs. Gd2 O3 NSs can be efficiently loaded with an anti-cancer drug (DOX, 80 %) and significantly inhibit tumor growth with negligible cellular and tissue toxicity both in vitro and in vivo. This study may provide a novel strategy to design tumor microenvironment-responsive inorganic nanomaterials for biocompatible bioimaging and biodegradation-enhanced cancer therapy.

Keywords: bioimaging; cancer therapy; gadolinium oxide; lanthanides; ultrathin structure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacology
  • Doxorubicin / administration & dosage
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology*
  • Drug Delivery Systems*
  • Gadolinium / chemistry*
  • Magnetic Resonance Imaging / methods*
  • Mice
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / metabolism
  • Neoplasms, Experimental / pathology*
  • Tumor Microenvironment*

Substances

  • Antibiotics, Antineoplastic
  • gadolinium oxide
  • Doxorubicin
  • Gadolinium